Senate plans future hearing on Cambridge Analytica, other firms

Go back to Senate plans future hearing on Cambridge Analytica, other firms

Oppenheimer Remains Bullish on Facebook (FB) Following Congressional Hearing

April 11, 2018 8:37 AM EDT

Oppenheimer Reiterated an Outperform rating and $225.00 price target on Facebook (NASDAQ: FB) following Mark Zuckerberg's congressional hearing with the Senate Judiciary, Science, Commerce & Transportation committees.

Analyst Jason Helfstein stated that "Mr. Zuckerberg appeared well prepared and delivered his answers in a congenial... More